MoneyWorks4Me

Dr. Reddy's receives EIR from USFDA for closure of inspection

21 Feb 2022 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) indicating closure of the inspection at its formulations manufacturing facilities (FTO 7 & FTO 9) at Duvvada in Visakhapatnam.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..